US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 1.250
  • -0.040-3.10%
Close Feb 26 16:00 ET
53.14MMarket Cap-0.63P/E (TTM)

About Repare Therapeutics Company

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

Company Profile

SymbolRPTX
Company NameRepare Therapeutics
Listing DateJun 19, 2020
Issue Price20.00
Founded2016
CEOMr. Lloyd M. Segal
MarketNASDAQ
Employees179
Fiscal Year Ends12-31
Address7171 Frederick-Banting,Suite 270
CitySaint-Laurent
ProvinceQuébec
CountryCanada
Zip CodeH4S 1Z9
Phone1-857-412-7018
Websitehttp://www.reparerx.com

Company Executives

  • Name
  • Position
  • Salary
  • Lloyd M. Segal
  • President, Chief Executive Officer and Director
  • 4.99M
  • Michael Zinda, PhD
  • Executive Vice President and Chief Scientific Officer
  • --
  • Dr. Maria Koehler, M.D.,PhD
  • Executive Vice President and Chief Medical Officer
  • 2.09M
  • Steve Forte
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 1.93M
  • Thomas Civik
  • Chairman of the Board
  • 291.49K
  • Dr. Steven H. Stein, M.D.
  • Director
  • --
  • Dr. David P. Bonita, M.D.
  • Independent Director
  • 265.41K
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 664.86K
  • Ann D. Rhoads
  • Independent Director
  • 274.74K
  • Carol A. Schafer
  • Independent Director
  • 272.99K
  • Dr. Samarth Kulkarni, PhD
  • Independent Director
  • 265.31K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
HENDERA
831152
+29.97%
LINGOOD
833284
+29.95%
4
WUHAN LAND
830779
+25.43%
5
TECHVISION
832876
+21.28%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!